FindTrial
Sign In

Serum D dimer and Procalcitonin Levels at Admission as Predictors of Severity in patients with Acute Pancreatitis

Serum D-dimer and procalcitonin levels at admission as predictors of severity in acute pancreatitis: an observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085322
Enrollment
62
Registered
2025-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K859- Acute pancreatitis, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

All India Institute of Medical Sciences Kalyani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients (18-70 years) with acute pancreatitis presenting within 24 hrs of symptom onset

Exclusion criteria

Exclusion criteria: 1. Pregnancy. 2. Patients presenting more than 24 hours of symptom onset. 3. Chronic pancreatitis 4. Recurrent pancreatitis 5. Age less than 18 years old or over 70 years old 6. Anticoagulant drug use 7. Cancer 8. Thrombotic diseases 9. Liver cirrhosis 10. Patient on immunosuppressive therapy 11. Refusal to give consent

Design outcomes

Primary

MeasureTime frame
1.To determine if serum D-dimer and procalcitonin levels at the time of admission can predict the severity of acute pancreatitis. Timepoint: Preparation and ethical approval-1-2 months Data collection- 3 months Data analysis, reporting and dissemination:1 month—

Secondary

MeasureTime frame
2.To evaluate whether D-dimer and procalcitonin levels are associated with the development of complications and mortality in patients with acute pancreatitis. 3.To determine the most reliable predictor between D-dimer and procalcitonin for early risk assessment in Acute Pancreatitis patients.Timepoint: Preparation and ethical approval-1-2 months Data collection- 3 months Data analysis, reporting and dissemination:1 month—

Countries

India

Contacts

Public ContactDr Biswajit Naskar

All India Institute of Medical Sciences Kalyani

mynameisjit310789@gmail.com6290074738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026